FCHI8,072.13-0.39%
GDAXI23,954.56-0.27%
DJI48,861.81-0.57%
XLE58.90-0.22%
STOXX50E5,816.48-0.34%
XLF51.67-0.48%
FTSE10,213.11-1.16%
IXIC24,673.240.04%
RUT2,739.47-0.60%
GSPC7,135.95-0.04%
Temp27.3°C
UV0
Feels30.5°C
Humidity84%
Wind17.6 km/h
Air QualityAQI 1
Cloud Cover25%
Rain86%
Sunrise05:58 AM
Sunset06:47 PM
Time9:46 PM
Markets
13F
Insiders
Press Releases
Companies
People
Cayman Journal
29 April 2026
13F HOLDINGS REPORT (Amended)

Mayo Clinic

Quarter ended Q1 2023 · Filed February 9, 2023 · Accession 0000950123-23-001228

Total Value
$188.8M
Positions
13
Other Managers
0
Confidential Omitted
No
View on SEC.gov

Holdings (13)

#IssuerTicker / CUSIPSharesValue% of Filing
1MSCI ACWI ETF4642882571,992,725$169.1M89.58%
2BLACK STONE MINERALSBSMLP643,617$10.9M5.75%
3Zentalis Pharmaceuticals IncZNTL297,143$6.0M3.17%
4EVELO BIOSCIENCES INCEVEX-WT479,242$771,5800.41%
5Miromatrix Med Inc60471P108191,622$572,9500.30%
6UNITY BIOTECHNOLOGY INCUNTCW157,198$430,7230.23%
7Clearpoint Neuro IncCLPT38,114$322,8260.17%
8Sorento Therapeutics83587F202300,000$267,0000.14%
9Neuroon Medical Technologies64130M209181,754$218,1050.12%
10Exact Sciences30063P1053,655$180,9590.10%
11BIOSIG TECH INC09073N201100,891$42,3740.02%
12Vyant Bio Inc92942V20827,742$19,4190.01%
13Teladoc Health Inc ComTDOC659$15,5850.01%